Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation

被引:11
作者
Hori, Yoshifumi [1 ]
Yamamoto, Hidetaka [1 ]
Nozaki, Yui [1 ]
Torisu, Takehiro [2 ]
Fujiwara, Minako [1 ]
Taguchi, Kenichi [3 ]
Nishiyama, Kenichi [4 ]
Nakamura, Shotaro [5 ]
Kitazono, Takanari [2 ]
Oda, Yoshinao [1 ]
机构
[1] Kyushu Univ, Dept Anat Pathol, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan
[3] Natl Kyushu Canc Ctr, Dept Pathol, Fukuoka, Japan
[4] Fukuoka Red Cross Hosp, Dept Pathol, Fukuoka, Japan
[5] Iwate Med Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Morioka, Iwate, Japan
关键词
Diffuse large B-cell lymphoma; Colon; Rectum; Translocation; Immunoglobulin; Prognosis; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; GASTROINTESTINAL-TRACT; MYC; EXPRESSION; BCL2; CHEMOTHERAPY; VINCRISTINE; DOXORUBICIN; FUSION;
D O I
10.1016/j.humpath.2019.09.003
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Primary colorectal diffuse large B-cell lymphoma (DLBCL) is rare, and its clinicopathological and genetic features are poorly understood. The aim of our study was to elucidate the frequency and prognostic significance of molecular subgroups in colorectal DLBCL. We examined 25 cases of colorectal lymphoma with DLBCL-like morphology and classified them into germinal center B-cell like (GCB)/non-GCB subgroups by immunohistochemistry (IHC) for CD10, bcl-6 and MUM1, or into double-expressor (DE)/non-DE subgroups by IHC for bcl-2 and c-myc. Translocations involving BCL2, BCL6, MYC, IGH, IGK, IGL, and MALT1 were also investigated using break-apart fluorescence in situ hybridization (FISH). The 25 cases were classified into two entities-DLBCL, not otherwise specified (NOS) (n = 23; 92%) and high grade B-cell lymphoma, double hit (n = 2; 8%)-according to the recent WHO classification. None of them showed histological evidence of Epstein-Barr virus infection or high-grade transformation from low grade B-cell lymphoma. Ten cases were GCB-type and four cases were DE-type, but these subtypes did not contribute to clinicopathological differences. Translocations involving BCL2, BCL6, MYC, IGH, IGK, IGL, and MALT1 were detected in 3 (12%), 3 (12%), 10 (40%), 14 (56%), 3 (12%), 3 (12%), and 0 (0%) of 25 cases, respectively. Of note, the presence of IGH translocation was significantly associated with better overall survival (P = .0053) and progression free survival (P = .0259). Similarly, the translocation involving at least one of the IGs (IGH, IGK, and/ or IGL) was associated with more favorable prognosis in DLBCLs or even in DLBCL, NOS. This is the first report to reveal that a small subset of colorectal DLBCL corresponds to double-hit lymphoma. In addition, translocations involving at least one of the IGs may be a favorable prognostic factor in colorectal DLBCL. Testing the translocation involving rearrangement of IGs as well as MYC and BCL2/ BCL6 may thus be useful for diagnosis and prognosis. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:67 / 78
页数:12
相关论文
共 38 条
[1]  
Akasaka H, 2000, CANCER RES, V60, P2335
[2]  
Akasaka T, 2000, BLOOD, V96, P2907
[3]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[4]   Double-hit B-cell lymphomas [J].
Aukema, Sietse M. ;
Siebert, Reiner ;
Schuuring, Ed ;
van Imhoff, Gustaaf W. ;
Kluin-Nelemans, Hanneke C. ;
Boerma, Evert-Jan ;
Kluin, Philip M. .
BLOOD, 2011, 117 (08) :2319-2331
[5]   Molecular cytogenetics of IGH rearrangements in non-Hodgkin B-cell lymphoma [J].
Bernicot, I. ;
Douet-Guilbert, N. ;
Le Bris, M. -J. ;
Herry, A. ;
Morel, F. ;
De Braekeleer, M. .
CYTOGENETIC AND GENOME RESEARCH, 2007, 118 (2-4) :345-352
[6]   The role of surgical intervention in primary colorectal lymphoma: A SEER population-based analysis [J].
Cai, Yi-bo ;
Chen, Hai-yan ;
He, Jin-jie ;
Hu, Ye-ting ;
Yang, Qi ;
Chen, Liu-bo ;
Xiao, Qian ;
Ding, Ke-feng .
ONCOTARGET, 2016, 7 (44) :72263-72275
[7]   A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy [J].
Choi, William W. L. ;
Weisenburger, Dennis D. ;
Greiner, Timothy C. ;
Piris, Miguel A. ;
Banham, Alison H. ;
Delabie, Jan ;
Braziel, Rita M. ;
Geng, Huimin ;
Iqbal, Javeed ;
Lenz, Georg ;
Vose, Julie M. ;
Hans, Christine P. ;
Fu, Kai ;
Smith, Lynette M. ;
Li, Min ;
Liu, Zhongfeng ;
Gascoyne, Randy D. ;
Rosenwald, Andreas ;
Ott, German ;
Rimsza, Lisa M. ;
Campo, Elias ;
Jaffe, Elaine S. ;
Jaye, David L. ;
Staudt, Louis M. ;
Chan, Wing C. .
CLINICAL CANCER RESEARCH, 2009, 15 (17) :5494-5502
[8]  
Gascoyne RD, 2017, WHO CLASSIFICATION T
[9]   Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone [J].
Green, Tina Marie ;
Young, Ken H. ;
Visco, Carlo ;
Xu-Monette, Zijun Y. ;
Orazi, Attilio ;
Go, Ronald S. ;
Nielsen, Ole ;
Gadeberg, Ole V. ;
Mourits-Andersen, Torben ;
Frederiksen, Mikael ;
Pedersen, Lars Moller ;
Moller, Michael Boe .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) :3460-3467
[10]   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Delabie, J ;
Ott, G ;
Müller-Hermelink, HK ;
Campo, E ;
Braziel, RM ;
Jaffe, ES ;
Pan, ZG ;
Farinha, P ;
Smith, LM ;
Falini, B ;
Banham, AH ;
Rosenwald, A ;
Staudt, LM ;
Connors, JM ;
Armitage, JO ;
Chan, WC .
BLOOD, 2004, 103 (01) :275-282